Science
Mechanism of Action
Inhibits tyrosinase enzyme activity to reduce melanin production while enhancing mitochondrial function and ATP synthesis. This dual approach diminishes hyperpigmentation while stimulating collagen, elastin, and keratin production in skin cells.
Research
Clinical Evidence
High confidence0.5%
Key findings
- 01 At 0.5%, matched or exceeded kojic dipalmitate performance in melanin reduction studies
- 02 1.0% concentration significantly enhanced mitochondrial activity and protein synthesis in human keratinocytes
- 03 Concentration range of 0.1-1.5% outperformed kojic acid in clinical brightening trials without irritation
Transparency
Dusting Analysis
Effective concentrations start at 0.1% with optimal results at 0.5-1.0%. Below 0.1% likely provides minimal brightening or cellular benefits.
The Formula
Formulation
Stability
Heat-sensitive compound requiring cool-phase addition below 40°C. Maintains stability across pH 3.5-8.5 range but performs optimally in slightly acidic conditions. High water solubility at 90g/L enables easy incorporation.
Synergies
- niacinamide
- vitamin C
- alpha arbutin
Conflicts
- high heat processing
- extreme pH formulations
Safety
Safety Profile
Widely used in major cosmetic brands at 0.5-2.0% concentrations. Supplier testing confirms non-cytotoxic and non-sensitizing properties at recommended usage levels.
Our Assessment
Verdict
A scientifically-backed brightening agent that uniquely combines pigmentation control with cellular energy enhancement at proven effective concentrations.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources